NEWS & MEDIA

Motif Bio Plc – Holding(s) in the Company

25 September 2017

Motif Bio plc, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 22 September 2017 by Amphion Innovations plc (“Amphion”) that a total of 4,390,000 ordinary shares in the Company had been sold in respect of a partial repayment of a loan facility, which is secured by Motif Bio shares held by Amphion.  Amphion is now the beneficial owner of 37,150,645 ordinary shares in the Company, representing 14.1% of the issued share capital.

 

Following this sale, Amphion has agreed an amendment to the loan facility with its lender such that no further Motif Bio shares will be sold before 15 January 2018. The full details of this amendment may be found in the RNS announcement released by Amphion today.

 

The TR-1 disclosure is set out below.

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

 

Motif Bio plc
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)

 

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)

 

An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

 

Name Amphion Innovations plc
City and country of registered office (if applicable)

 

4. Full name of shareholder(s) (if different from 3.)v

 

Name
City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

 

September 22 2017

 

6. Date on which issuer notified (DD/MM/YYYY):

 

September 22 2017

 

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 14.1% 263,128,775
Position of previous notification (if

applicable)

15.8%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

 

A: Voting rights attached to shares

 

Class/type of
shares
ISIN code (if possible)
Number of voting rightsix

 

% of voting rights

 

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB008BVVT4H71 37,150,645 14.1%
 

 

SUBTOTAL 8. A 37,150,645 14.1%
 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

 

Type of financial instrument Expiration
date
x
Exercise/
Conversion Period
xi
Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights
SUBTOTAL 8. B 1
 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

 

Type of financial instrument Expiration
date
x
Exercise/
Conversion Period 
xi
Physical or cash

settlementxii

Number of voting rights % of voting rights
SUBTOTAL 8.B.2
 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv(please add additional rows as necessary) 
Namexv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting, please identify:

 

Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
 

 

11. Additional informationxvi

 

 

Place of completion
Date of completion September 22 2017

 

This information is provided by RNS

The company news service from the London Stock Exchange

c.